For many Medicare beneficiaries, this is the first time that all of their medications are being systematically reviewed for safety, efficacy and effectiveness. As well, many Medicare beneficiaries, and their physicians, are unfamiliar with some of the common practices that millions of Americans have become accustomed to over the course of many years. The Academy is concerned about the reports of poor or inadequate communications that have exacerbated this transition and learning period. |